Meiji Yasuda Life Insurance Co Sells 5,910 Shares of Dow Chemical Co (DOW)

Meiji Yasuda Life Insurance Co trimmed its holdings in Dow Chemical Co (NYSE:DOW) by 13.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,762 shares of the basic materials company’s stock after selling 5,910 shares during the period. Meiji Yasuda Life Insurance Co’s holdings in Dow Chemical were worth $2,319,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in shares of Dow Chemical by 7.6% during the first quarter. Vanguard Group Inc. now owns 81,191,459 shares of the basic materials company’s stock valued at $5,158,905,000 after purchasing an additional 5,722,128 shares in the last quarter. Jana Partners LLC bought a new position in shares of Dow Chemical during the first quarter valued at about $225,688,000. Glenview Capital Management LLC lifted its position in shares of Dow Chemical by 34.8% during the first quarter. Glenview Capital Management LLC now owns 11,864,132 shares of the basic materials company’s stock valued at $753,847,000 after purchasing an additional 3,066,049 shares in the last quarter. Ameriprise Financial Inc. lifted its position in shares of Dow Chemical by 26.8% during the first quarter. Ameriprise Financial Inc. now owns 10,592,146 shares of the basic materials company’s stock valued at $674,160,000 after purchasing an additional 2,237,295 shares in the last quarter. Finally, FMR LLC lifted its position in shares of Dow Chemical by 11.8% during the first quarter. FMR LLC now owns 15,503,280 shares of the basic materials company’s stock valued at $985,078,000 after purchasing an additional 1,638,866 shares in the last quarter. 67.77% of the stock is currently owned by hedge funds and other institutional investors.

DOW has been the topic of a number of recent analyst reports. Cowen and Company reissued a “hold” rating and set a $60.00 price target on shares of Dow Chemical in a research report on Monday, August 28th. Alembic Global Advisors set a $85.00 price objective on shares of Dow Chemical and gave the stock a “buy” rating in a research report on Thursday, July 27th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $76.00 price objective on shares of Dow Chemical in a research report on Thursday, July 6th. BidaskClub raised shares of Dow Chemical from a “sell” rating to a “hold” rating in a research report on Wednesday, August 23rd. Finally, Jefferies Group LLC reaffirmed a “buy” rating on shares of Dow Chemical in a research report on Tuesday, August 29th. One analyst has rated the stock with a sell rating, four have issued a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. Dow Chemical has a consensus rating of “Buy” and a consensus target price of $72.02.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.com-unik.info/2017/11/02/meiji-yasuda-life-insurance-co-sells-5910-shares-of-dow-chemical-co-dow.html.

Dow Chemical Profile

Want to see what other hedge funds are holding DOW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dow Chemical Co (NYSE:DOW).

Institutional Ownership by Quarter for Dow Chemical (NYSE:DOW)

What are top analysts saying about Dow Chemical Co? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Dow Chemical Co and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit